Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · IEX Real-Time Price · USD
2.790
-0.160 (-5.42%)
May 7, 2024, 4:30 PM EDT - Market closed

LIXT Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2006
Net Income
-5.09-6.31-6.73-3.26-2.44-2.13-1.81-2.13-2.85-2.77
Upgrade
Share-Based Compensation
0.771.552.61.250.750.790.070.290.550.95
Upgrade
Other Operating Activities
0.020.15-0.01-0.120.02-0.160.330.170.120.18
Upgrade
Operating Cash Flow
-4.29-4.61-4.14-2.13-1.67-1.51-1.41-1.68-2.18-1.64
Upgrade
Change in Investments
-1.150.53-0.252.47-1.672.971.110.10.09-0.21
Upgrade
Other Investing Activities
--------0.02-
Upgrade
Investing Cash Flow
-1.150.53-0.252.47-1.672.971.110.10.11-0.21
Upgrade
Share Issuance / Repurchase
3.145.143.94.604.482.5200.321.41
Upgrade
Other Financing Activities
-------1.751.74-
Upgrade
Financing Cash Flow
3.145.143.94.604.482.521.752.051.41
Upgrade
Net Cash Flow
-1.150.53-0.252.47-1.672.971.110.17-0.02-0.43
Upgrade
Free Cash Flow
-4.29-4.61-4.14-2.13-1.67-1.51-1.41-1.68-2.18-1.64
Upgrade
Free Cash Flow Per Share
-2.24-2.92-3.08-1.89-1.50-1.54-1.52-2.10-2.80-2.21
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).